BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhao W, Esquinas PL, Frezza A, Hou X, Beauregard JM, Celler A. Accuracy of kidney dosimetry performed using simplified time activity curve modelling methods: a 177Lu-DOTATATE patient study. Phys Med Biol 2019;64:175006. [PMID: 31287093 DOI: 10.1088/1361-6560/ab3039] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Monserrat Fuertes T, González García FM, Peinado Montes MÁ, Domínguez Grande ML, Martín Fernández N, Gómez de Iturriaga Piña A, Mínguez Gabiña P. Description of the methodology for dosimetric quantification in treatments with 177Lu-DOTATATE. Rev Esp Med Nucl Imagen Mol (Engl Ed) 2021;40:167-78. [PMID: 33811003 DOI: 10.1016/j.remn.2021.02.006] [Reference Citation Analysis]
2 Vergnaud L, Giraudet AL, Moreau A, Salvadori J, Imperiale A, Baudier T, Badel JN, Sarrut D. Patient-specific dosimetry adapted to variable number of SPECT/CT time-points per cycle for [Formula: see text]Lu-DOTATATE therapy. EJNMMI Phys 2022;9:37. [PMID: 35575946 DOI: 10.1186/s40658-022-00462-2] [Reference Citation Analysis]
3 Freedman N, Sandström M, Kuten J, Shtraus N, Ospovat I, Schlocker A, Even-Sapir E. Personalized radiation dosimetry for PRRT-how many scans are really required? EJNMMI Phys 2020;7:26. [PMID: 32394075 DOI: 10.1186/s40658-020-00293-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
4 Piwowarska-bilska H, Kurkowska S, Birkenfeld B. Individualization of Radionuclide Therapies: Challenges and Prospects. Cancers 2022;14:3418. [DOI: 10.3390/cancers14143418] [Reference Citation Analysis]
5 Ramonaheng K, van Staden JA, du Raan H. Accuracy of two dosimetry software programs for 177Lu radiopharmaceutical therapy using voxel-based patient-specific phantoms. Heliyon 2022;8:e09830. [PMID: 35865988 DOI: 10.1016/j.heliyon.2022.e09830] [Reference Citation Analysis]
6 Nautiyal A, Mondal T, Mitra D, Goel A, Dey SK, Kaushik A. A SIMPLE AND NOVEL APPROACH TO STUDY KINETICS AND ESTIMATE RADIATION DOSES FROM INTERNALLY ADMINISTERED RADIOPHARMACEUTICALS USING AN EXTERNAL DOSE MEASUREMENT SYSTEM. Radiat Prot Dosimetry 2021;196:141-52. [PMID: 34585244 DOI: 10.1093/rpd/ncab141] [Reference Citation Analysis]
7 Graves SA, Bageac A, Crowley JR, Merlino DAM. Reimbursement Approaches for Radiopharmaceutical Dosimetry: Current Status and Future Opportunities. J Nucl Med 2021;62:48S-59S. [PMID: 34857622 DOI: 10.2967/jnumed.121.262752] [Reference Citation Analysis]
8 Devasia TP, Dewaraja YK, Frey KA, Wong KK, Schipper MJ. A Novel Time-Activity Information-Sharing Approach Using Nonlinear Mixed Models for Patient-Specific Dosimetry with Reduced Imaging Time Points: Application in SPECT/CT After 177Lu-DOTATATE. J Nucl Med 2021;62:1118-25. [PMID: 33443063 DOI: 10.2967/jnumed.120.256255] [Reference Citation Analysis]
9 Malcolm JC, Falzone N, Gains JE, Aldridge MD, Mirando D, Lee BQ, Gaze MN, Vallis KA. Impact of cyclic changes in pharmacokinetics and absorbed dose in pediatric neuroblastoma patients receiving [177Lu]Lu-DOTATATE. EJNMMI Phys 2022;9. [DOI: 10.1186/s40658-022-00436-4] [Reference Citation Analysis]